68 related articles for article (PubMed ID: 29387226)
1. Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review.
Aderinto N; Abdulbasit MO; Olatunji D; Edun M
Ann Med Surg (Lond); 2023 Nov; 85(11):5557-5567. PubMed ID: 37915694
[TBL] [Abstract][Full Text] [Related]
2. The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma.
Xiao ZJ; Wang SQ; Chen JJ; Li Y; Jiang Y; Tin VP; Liu J; Hu H; Wong MP; Pan Y; Yam JWP
Adv Sci (Weinh); 2024 May; 11(20):e2306059. PubMed ID: 38528665
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Relationship Between miRNA-22-3p and Gal-9 Levels in Glioblastoma.
Barut Z; Akdeniz FT
In Vivo; 2023; 37(6):2577-2584. PubMed ID: 37905655
[TBL] [Abstract][Full Text] [Related]
4. A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9).
Lv Y; Ma X; Ma Y; Du Y; Feng J
Genes Dis; 2023 Nov; 10(6):2366-2382. PubMed ID: 37554219
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 and myeloid-derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia.
Alimu X; Zhang J; Pang N; Zhang R; Chen R; Zeng X; Tudahong S; Chen G; Muhashi M; Zhao F; Ding J; Qu J
Immun Inflamm Dis; 2023 May; 11(5):e853. PubMed ID: 37249287
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 in Gastroenterological Cancer.
Morishita A; Oura K; Tadokoro T; Shi T; Fujita K; Tani J; Atsukawa M; Masaki T
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047155
[TBL] [Abstract][Full Text] [Related]
7. Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
Shi Y; Tang D; Li X; Xie X; Ye Y; Wang L
Front Oncol; 2022; 12():889034. PubMed ID: 35677161
[TBL] [Abstract][Full Text] [Related]
8. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels.
Seifert AM; Reiche C; Heiduk M; Tannert A; Meinecke AC; Baier S; von Renesse J; Kahlert C; Distler M; Welsch T; Reissfelder C; Aust DE; Miller G; Weitz J; Seifert L
Oncogene; 2020 Apr; 39(15):3102-3113. PubMed ID: 32055023
[TBL] [Abstract][Full Text] [Related]
9. TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway.
Han H; Zhan Z; Xu J; Song Z
Onco Targets Ther; 2019; 12():11371-11382. PubMed ID: 31920328
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H
Front Physiol; 2018; 9():452. PubMed ID: 29765332
[No Abstract] [Full Text] [Related]
12. Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.
Kobayashi K; Morishita A; Iwama H; Fujita K; Okura R; Fujihara S; Yamashita T; Fujimori T; Kato K; Kamada H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2015 Oct; 34(4):1761-70. PubMed ID: 26260906
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9: An anticancer molecule for gallbladder carcinoma.
Tadokoro T; Morishita A; Fujihara S; Iwama H; Niki T; Fujita K; Akashi E; Mimura S; Oura K; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2016 Mar; 48(3):1165-74. PubMed ID: 26797414
[TBL] [Abstract][Full Text] [Related]
14. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.
Akashi E; Fujihara S; Morishita A; Tadokoro T; Chiyo T; Fujikawa K; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
Oncol Rep; 2017 Jul; 38(1):506-514. PubMed ID: 28586026
[TBL] [Abstract][Full Text] [Related]
15. Highlights on the Role of Galectin-3 in Colorectal Cancer and the Preventive/Therapeutic Potential of Food-Derived Inhibitors.
Aureli A; Del Cornò M; Marziani B; Gessani S; Conti L
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612048
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.
Okura R; Fujihara S; Iwama H; Morishita A; Chiyo T; Watanabe M; Hirose K; Kobayashi K; Fujimori T; Kato K; Kamada H; Kobara H; Mori H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
Oncol Lett; 2018 Jan; 15(1):407-414. PubMed ID: 29387226
[TBL] [Abstract][Full Text] [Related]
17. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T
Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
